Big Pharma Profiteering off PentagonSubmitted by yankee on Sun, 12/30/2012 - 15:59
The details come from an unprecedented American-Statesman analysis of nearly every individual drug purchase made by the Department of Defense since 2002. The paper’s analysis also showed that many drug manufacturers saw their revenue from military sales soar over a decade that featured two wars and a large influx of beneficiaries covered by Tricare, the military’s health program.
They were led by giant Pfizer, with more than $8 billion in sales from the Department of Defense since 2002. Abbott’s sales jumped nearly 300 percent and Novartis more than doubled its military sales to around $400 million in 2011, according to data provided by the military.